Cytek Biosciences, Inc. (CTKB)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous Close | 6.38 |
| Open | 6.28 |
| Bid | 6.25 x 100 |
| Ask | 6.31 x 100 |
| Day's Range | 6.24 - 6.35 |
| 52 Week Range | 3.80 - 10.90 |
| Volume | |
| Avg. Volume | 721,226 |
| Market Cap | 823.025M |
| Beta (5Y Monthly) | 1.37 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Zacks
Cytek Biosciences, Inc. (CTKB) Stock Moves -0.33%: What You Should Know
In the most recent trading session, Cytek Biosciences, Inc. (CTKB) closed at $6.01, indicating a -0.33% shift from the previous trading day.
- Zacks
Cytek Biosciences (CTKB) Is Considered a Good Investment by Brokers: Is That True?
The average brokerage recommendation (ABR) for Cytek Biosciences (CTKB) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
- Zacks
Cytek Biosciences (CTKB) Loses -7.27% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
The heavy selling pressure might have exhausted for Cytek Biosciences (CTKB) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
© 2024 Yahoo. All rights reserved.